Amoxicillin
Brand names: Amoxil
Amoxicillin is a broad-spectrum aminopenicillin antibiotic for respiratory, ENT, urinary and other infections, and part of Helicobacter pylori regimens.
Adult dose
Dose adjustments
§4.2: GFR greater than 30 ml/min — no adjustment necessary (adults, children 40 kg or more, and children under 40 kg). GFR 10 to 30 ml/min — adults and children 40 kg or more: maximum 500 mg twice daily; children under 40 kg: 15 mg/kg given twice daily. GFR less than 10 ml/min — adults and children 40 kg or more: maximum 500 mg/day; children under 40 kg: 15 mg/kg given as a single daily dose. In the majority of cases parenteral therapy is preferred for children under 40 kg. HAEMODIALYSIS — adults and children over 40 kg: 500 mg every 24 hours, with one additional 500 mg dose prior to haemodialysis and another 500 mg after haemodialysis to restore circulating drug levels; children under 40 kg: 15 mg/kg/day as a single daily dose (maximum 500 mg), with an additional 15 mg/kg before and 15 mg/kg after haemodialysis. PERITONEAL DIALYSIS: maximum 500 mg/day.
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
US labelling (FDA)
Reference — US labelling, may differ from UKAdults and Pediatric Patients greater than 40 kg: 500 or 875 mg every 12 hours or 250 or 500 mg every 8 hours, based on the amoxicillin component. ( 2.2 , 2.3 ) Pediatric patients aged 12 weeks (3 months) and older: 25 to 45 mg/kg/day every 12 hours or 20 to 40 mg/kg/day every 8 hours, up to the adult dose. ( 2.3 ) Neonates and infants less than 12 weeks of age: 30 mg/kg/day divided every 12 hours, based on the amoxicillin component. Use of the 125 mg/5 mL oral suspension is recommended. ( 2.3 ) 2.1 Important Administration Instructions Amoxicillin and Clavulanate Potassium may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when Amoxicillin and …
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2024-04-30. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Contraindications
- Hypersensitivity to the active substance, to any of the penicillins, or to any of the excipients
- History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam)
Side effects
- Diarrhoea and nausea (common) — the most commonly reported reactions, with vomiting (uncommon)
- Skin rash (common); urticaria and pruritus (uncommon)
- Severe allergic reactions including angioneurotic oedema, anaphylaxis, serum sickness and hypersensitivity vasculitis (very rare); Kounis syndrome (not known); Jarisch-Herxheimer reaction after treatment of Lyme disease (not known)
- Severe cutaneous reactions — erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous and exfoliative dermatitis, acute generalised exanthematous pustulosis (AGEP) and DRESS (very rare)
- Antibiotic associated colitis including pseudomembranous and haemorrhagic colitis, hepatitis and cholestatic jaundice, interstitial nephritis, crystalluria including acute renal injury, reversible leucopenia, thrombocytopenia and haemolytic anaemia, hyperkinesia, dizziness and convulsions (very rare); aseptic meningitis (not known)
Clinical monograph
How it works
A beta-lactam that inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins.
Prescribing in practice
- Avoid in penicillin allergy.
- It commonly causes a non-allergic rash if given during glandular fever (infectious mononucleosis).
- Like other antibiotics it can predispose to Clostridioides difficile and, rarely, hypersensitivity.
Monitoring
Short courses need no routine monitoring; review the response.
Counselling the patient
- Complete the course.
- Report a rash, wheeze or facial swelling (possible allergy).
- Report severe or prolonged diarrhoea.
Evidence & guidelines
A first-line antibiotic for many community infections (NICE/local antimicrobial guidance).
Reference: NICE NG138 (Pneumonia); PHE Antibiotic Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Centor / McIsaac Score for Strep Pharyngitis · Throat
- Acute Otitis Media Severity (AOM-SOS) · Otitis Media
- Centor/McIsaac Score (Pharyngitis) · Throat Infections
- IE Prophylaxis Indication · Treatment
- FeverPAIN Score for Strep Throat · Throat
- Jarisch-Herxheimer Reaction Severity Assessment · Treatment Reactions
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
- Chronic Fatigue Workup · NICE NG206; BMJ Best Practice
- Lymphadenopathy Workup · NICE NG12; BMJ Best Practice
- Pre-op Medical Clearance · NICE NG45; ESC 2022
- Secondary Hypertension Workup · NICE NG136; ESH 2023